Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Ancient genomes revisit the ancestry of domestic and Przewalski's horses.

Gaunitz C, Fages A, Hanghøj K, Albrechtsen A, Khan N, Schubert M, Seguin-Orlando A, Owens IJ, Felkel S, Bignon-Lau O, de Barros Damgaard P, Mittnik A, Mohaseb AF, Davoudi H, Alquraishi S, Alfarhan AH, Al-Rasheid KAS, Crubézy E, Benecke N, Olsen S, Brown D, Anthony D, Massy K, Pitulko V, Kasparov A, Brem G, Hofreiter M, Mukhtarova G, Baimukhanov N, Lõugas L, Onar V, Stockhammer PW, Krause J, Boldgiv B, Undrakhbold S, Erdenebaatar D, Lepetz S, Mashkour M, Ludwig A, Wallner B, Merz V, Merz I, Zaibert V, Willerslev E, Librado P, Outram AK, Orlando L.

Science. 2018 Apr 6;360(6384):111-114. doi: 10.1126/science.aao3297. Epub 2018 Feb 22.

PMID:
29472442
2.

Pre-Clovis occupation 14,550 years ago at the Page-Ladson site, Florida, and the peopling of the Americas.

Halligan JJ, Waters MR, Perrotti A, Owens IJ, Feinberg JM, Bourne MD, Fenerty B, Winsborough B, Carlson D, Fisher DC, Stafford TW Jr, Dunbar JS.

Sci Adv. 2016 May 13;2(5):e1600375. doi: 10.1126/sciadv.1600375. eCollection 2016 May.

3.

FK962 and donepezil act synergistically to improve cognition in rats: potential as an add-on therapy for Alzheimer's disease.

McCarthy AD, Owens IJ, Bansal AT, McTighe SM, Bussey TJ, Saksida LM.

Pharmacol Biochem Behav. 2011 Mar;98(1):76-80. doi: 10.1016/j.pbb.2010.11.019. Epub 2010 Dec 2.

PMID:
21130801
4.

Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza.

Macdonald SJ, Cameron R, Demaine DA, Fenton RJ, Foster G, Gower D, Hamblin JN, Hamilton S, Hart GJ, Hill AP, Inglis GG, Jin B, Jones HT, McConnell DB, McKimm-Breschkin J, Mills G, Nguyen V, Owens IJ, Parry N, Shanahan SE, Smith D, Watson KG, Wu WY, Tucker SP.

J Med Chem. 2005 Apr 21;48(8):2964-71.

PMID:
15828835
5.

Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen.

Macdonald SJ, Watson KG, Cameron R, Chalmers DK, Demaine DA, Fenton RJ, Gower D, Hamblin JN, Hamilton S, Hart GJ, Inglis GG, Jin B, Jones HT, McConnell DB, Mason AM, Nguyen V, Owens IJ, Parry N, Reece PA, Shanahan SE, Smith D, Wu WY, Tucker SP.

Antimicrob Agents Chemother. 2004 Dec;48(12):4542-9.

6.

High-order Cerenkov laser gain.

Owens IJ, Brownell JH.

Phys Rev E Stat Nonlin Soft Matter Phys. 2003 Mar;67(3 Pt 2):036611. Epub 2003 Mar 20.

PMID:
12689183
7.

Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene.

Abed Y, Bourgault AM, Fenton RJ, Morley PJ, Gower D, Owens IJ, Tisdale M, Boivin G.

J Infect Dis. 2002 Oct 15;186(8):1074-80. Epub 2002 Sep 30.

PMID:
12355356
8.

Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies.

Barnett JM, Cadman A, Gor D, Dempsey M, Walters M, Candlin A, Tisdale M, Morley PJ, Owens IJ, Fenton RJ, Lewis AP, Claas EC, Rimmelzwaan GF, De Groot R, Osterhaus AD.

Antimicrob Agents Chemother. 2000 Jan;44(1):78-87.

9.

Chemoprophylaxis of influenza A virus infections, with single doses of zanamivir, demonstrates that zanamivir is cleared slowly from the respiratory tract.

Fenton RJ, Morley PJ, Owens IJ, Gower D, Parry S, Crossman L, Wong T.

Antimicrob Agents Chemother. 1999 Nov;43(11):2642-7.

10.

The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en.

Blick TJ, Sahasrabudhe A, McDonald M, Owens IJ, Morley PJ, Fenton RJ, McKimm-Breschkin JL.

Virology. 1998 Jun 20;246(1):95-103.

Supplemental Content

Loading ...
Support Center